Cargando…
GeneXpert MTB/RIF Version G4 for Identification of Rifampin-Resistant Tuberculosis in a Programmatic Setting
A recent Cochrane review estimated GeneXpert MTB/RIF specificity for rifampin resistance as 98% (95% confidence interval [CI], 97 to 99), based on results from earlier test versions. The measured positive predictive value of the new generation test from programmatic implementation in Cape Town, Sout...
Autores principales: | Osman, Muhammad, Simpson, John A., Caldwell, Judy, Bosman, Marlein, Nicol, Mark P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3911341/ https://www.ncbi.nlm.nih.gov/pubmed/24478501 http://dx.doi.org/10.1128/JCM.02517-13 |
Ejemplares similares
-
Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014) -
An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag
por: Esmail, Aliasgar, et al.
Publicado: (2020) -
Diagnostic Accuracy of the Truenat MTB Plus Assay and Comparison with the Xpert MTB/RIF Assay to Detect Tuberculosis among Hospital Outpatients in Cameroon
por: Ngangue, Yannick Russel, et al.
Publicado: (2022) -
Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting
por: Opota, Onya, et al.
Publicado: (2019) -
Evaluation of Xpert MTB/RIF Ultra Assay for Diagnosis of Childhood Tuberculosis: a Multicenter Accuracy Study
por: Sun, Lin, et al.
Publicado: (2020)